Header Logo

Connection

Lynn Morris to Clinical Trials, Phase I as Topic

Back to Details
This is a "connection" page, showing publications Lynn Morris has written about Clinical Trials, Phase I as Topic.
Lynn Morris
Connection Strength
0,042
Clinical Trials, Phase I as Topic
  1. Assessing the safety and pharmacokinetics of the monoclonal antibodies, VRC07-523LS and PGT121 in HIV negative women in South Africa: study protocol for the CAPRISA 012A randomised controlled phase I trial. BMJ Open. 2019 07 03; 9(7):e030283.
    View in: PubMed
    Score: 0,042
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.